GP-119 (GliaPharm)

N/A

Report date: 2025/05/29 09:15:37
NME

Base Information

Drug NameGP-119 (GliaPharm)
Drug Alias NameGP-119
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGliapharm Sa
China Registration ClassN/A

Develop Information

Active CompaniesGliapharm Sa
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A